On Tuesday, it was reported by Barry Jackson of the Miami Herald that veteran cornerback Rasul Douglas visited the Miami ...

GSK will acquire liver-disease treatment efimosfermin from Boston Pharmaceuticals for up to $2 billion to expand its portfolio. The British pharma giant said Wednesday that it will pay the U.S.

DHL Group, the world’s leading logistics provider, has signed a strategic Memorandum of Understanding (MOU) with Boston ...

demonstrating the team will not pay any price to own those quality firms. Unlike its sibling Boston Trust SMID Cap, this offering has an impact mandate and therefore incorporates exclusionary ESG ...

Boston Scientific strutted into the Bank of America Healthcare Conference with a swagger backed by 18.2% organic revenue ...